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aThis review is a sequel to our 7 previous reports highlighting
the most important published research with regard to
myocardial perfusion imaging (MPI) with single-photon
emission computed tomography (SPECT), cardiac positron
emission tomography (PET), cardiac computed tomogra-
phy (CT), and cardiac magnetic resonance imaging (MRI).
This report generally covers the English-language literature
between July 1, 2010, and June 30, 2011.
We continue to believe that an integrated, multi-
modality imaging approach is ideal for the solution of most
clinical problems and have therefore organized the summary
around topical themes.
Technical Developments
SPECT. Last year, we reported on the first large clinical
study (1) using the new cadmium zinc telluride solid state
detectors with the Spectrum Dynamics D-SPECT (Spec-
trum Dynamics, Danville, California) camera. This year, an
important clinical study of SPECT imaging with a different
cadmium zinc telluride detector camera, the GE Healthcare
Discovery NM530C (GE Healthcare, Milwaukee, Wiscon-
sin), was published by Gimelli et al. (2). They investigated
34 patients who underwent 1-day technetium-99m tetro-
fosmin imaging with conventional SPECT and the new
ultrafast camera (UFC). The UFC compared favorably with
SPECT in this small series.
CT. After-hours reporting of coronary imaging studies in
atients with chest pain could be facilitated by viewing
maging studies on portable devices. A pilot study on 102
atients performed by LaBounty et al. (3), examined the
iagnostic accuracy of coronary computed tomographic
ngiography (CTA) as interpreted on a mobile handheld
hone device. The transfer of all full-resolution images of a
oronary CTA study to the portable device typically took
5 min. The portable device screen had an 8.9-cm diagonal
ize and a resolution of 480 320 pixels (Fig. 1). Compared
with traditional image interpretation on a dedicated work-
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showed a nonsignificant trend toward reduced specificity.
Previous studies of coronary CTA have shown high
interobserver variability. The improvement of image quality
on current CTA allows the use of automated, software-
based quantitation of stenosis. Automated analysis of the
most severe lesion on quantitative 64-slice coronary CTA in
100 patients by Boogers et al. (4) showed good correlation
with quantitative invasive coronary angiography on a per-
vessel analysis (n  282; r  0.83; p  0.01) with a mean
difference of3.0 12.3%. For patients who had moderate
or good image quality, the positive predictive value for
detecting 50% diameter stenosis on invasive coronary
angiography was significantly higher for quantitative coro-
nary CTA than for visual stenosis assessment (100% vs.
78%; p  0.05).
MRI. In a typical cardiac MRI examination, cine images
are acquired in a series of 2-dimensional (2D) acquisitions
in separate breath-holds to calculate ventricular volumes.
Although it would be desirable to acquire ventricular vol-
umes in a single 3-dimensional (3D) acquisition in a single
breath-hold, previous methods that allowed for scan times
that were short enough to cover the ventricles in a single
breath-hold had significantly decreased image quality.
Liu et al. (5) shortened scan time by combining 2
previously used techniques (radial acquisition and multi-
echo acquisition). They performed a 3D cine acquisition in
a single 17-s breath-hold while maintaining spatial resolu-
tion comparable to conventional 2D images (1.2  1.2  8
m). In 8 healthy volunteers, the left ventricular ejection
raction (LVEF) measured from the 3D acquired images
as comparable to those from a standard 2D, multislice
cquisition, with a difference of 1.7  4.3%.
atient Safety
PECT/general radiation risk. Exposure of patients to
onizing radiation and risk estimates for cancer related to
ardiac imaging involving radiation continue to be of great
nterest.
Berrington de Gonzalez et al. (6) reported projected
opulation cancer risks from current levels of SPECT scans
n the United States. Cumulative lifetime risks varied by type of
can and age at time of scanning but not by sex if summed
cross all organs. The authors estimated that the 9.1 million
PECT scans performed annually in the United States could
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Year in Cardiac Imaging May 22, 2012:1849–60result in 7,400 additional future cancers. The authors con-
cluded that the “lifetime cancer risk from a single myocardial
perfusion scan is small and should be balanced against likely
benefit and appropriateness of the test.”
Einstein et al. (7) characterized the number of imaging
procedures involving radiation and cumulative effective
doses of radiation over 20 years in 1 center in 1,097
consecutive patients (age 62.2 13.1 years) who underwent
an index SPECT. The cumulative effective dose estimate
was 100 mSv for 31% of the patients. Multiple SPECT
scans were performed in 39% of patients, for whom the
cumulative median effective dose estimate was 121 mSv
(interquartile range 81 to 189 mSv; mean 149 mSv). More
than 80% of the initial and 90% of the repeat SPECT scans
were performed in patients who had known or suspected
coronary artery disease (CAD). A “clear majority” were
performed for appropriate indications.
Kaul et al. (8) estimated the cumulative effective dose related
to all imaging studies for 1 episode of care for acute myocardial
infarction (MI) in 49 centers. For 64,071 acute MI (median
patient age, 65 years), a total of 276,651 procedures with
radiation were performed, with a median of 4.3 procedures/
patient. A majority of patients had invasive coronary angiog-
raphy (77%) and body CT (52%). The mean cumulative
effective dose estimate was 15 mSv. Patients with higher
severity of illness scores had higher radiation exposure and
higher mortality (p 0.0001) than those with lower severity of
llness scores. In an accompanying editorial, Wijns et al. (9) were
eassured by these findings, because radiation exposure was driven
rimarily by the severity of illness and complications.
TA dose reduction. Various scanning approaches and
rotocols that reduce the radiation dose received from
ardiac CT were highlighted in a series of detailed recom-
endations from the Society for Cardiovascular Computed
Figure 1 Coronary Computed Tomography Angiography Interpre
Coronary computed tomography angiography image of a proximal left anterior desc
and a mobile handheld phone device (B), viewed at identical window width and leomography (10). mReducing the tube current during all or part of the cardiac
ycle to reduce patient dose will lead to higher noise and
educed image quality for the images reconstructed with
ltered back projection (FBP). A different approach to
mage reconstruction, so-called iterative reconstruction
IR), is commonly used in SPECT but not in CT. Iterative
econstruction uses an iterative process of mathematical
odeling to identify and selectively reduce noise.
Leipsic et al. (11) performed a prospective study of 574
onsecutive patients at 3 medical centers to compare IR and
BP. An initial group of 331 studies with FBP was compared
ith a subsequent group of 243 studies with IR. The coronary
TA reconstructed with IR had a 31%-lower median tube
urrent and a 44%-lower median effective dose than those
econstructed with FBP, with no difference in image noise.
Other studies comparing coronary CTA between stan-
ard and low-dose scanning protocols (12–15) in prospec-
ive and/or randomized fashion are summarized in Table 1.
RI. Under certain conditions, noncardiac MRI may be
erformed safely in patients with cardiac pacemakers and
mplantable cardioverters/defibrillators. Two recent small
tudies by Naehle et al. (16) and Buendia et al. (17) have
xtended this finding to cardiac MRI. Patients in these
tudies were highly selected, carefully monitored during
canning, and underwent rigorous evaluation of their de-
ices both before and after MRI.
iagnosis: CAD
T calcium score. Advocates of coronary calcium scoring
CAC) in asymptomatic individuals have suggested that it
ill improve treatment of risk factors. Rozanski et al. (18)
erformed a single-center prospective randomized trial in
,137 asymptomatic subjects to compare risk factor modi-
cation according to existing practice with risk factor
n a Handheld Device
artery occlusion (arrows) as seen on a dedicated workstation computer (A)
tings. Reprinted, with permission, from LaBounty et al. (3).ted o
ending
vel setodification with CAC scanning. Multiple risk factors
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May 22, 2012:1849–60 Year in Cardiac Imagingshowed more favorable changes in the CAC group com-
pared with the existing practice group. Overall downstream
costs were similar in both groups. There is a need for future
large-scale clinical trials with assessment of adverse clinical
events.
CT/SPECT or PET. Although the potentially comple-
mentary nature of stress imaging studies for ischemia and
coronary CTA for anatomy has long been recognized,
previous studies have shown an imperfect relationship be-
tween these 2 approaches. Two studies during the past year
provided important clarification.
Van Velzen et al. (19) performed stress SPECT and
coronary CTA in 514 patients, 137 (27%) of whom had
ischemia by SPECT. As expected, the presence of a 70%
tenosis by CTA was strongly associated with ischemia
odds ratio: 3.5). Plaque extent and composition as well as
eft main and/or proximal LAD location were also indepen-
ent predictors of ischemia and added significantly to the
rea under the receiver-operating characteristic curve
ROC).
Kajander et al. (20) performed stress PET and CTA in
07 patients with an intermediate likelihood of CAD. The
ET studies employed quantitative blood flow determina-
ion with oxygen-15–labeled water and adenosine stress.
he authors compared PET and CTA with quantitative
nvasive coronary angiography, including fractional flow
eserve in intermediate stenoses. On a per-patient and
er-vessel basis, hybrid imaging with PET and CTA was
ore accurate than CTA or PET alone. This hybrid
pproach could be performed with 10 mSv radiation dose
in most patients.
CT: stress perfusion. The potential ability of cardiac CT
to assess the physiological significance of coronary artery
stenoses by adenosine-induced stress MPI continues to
be of great interest. Ho et al. (21) used adenosine stress
CT MPI with 128-slice dual-source CT in patients with
known SPECT perfusion defects. In 544 myocardial
segments in 32 patients, the sensitivity of CT to identify
SPECT perfusion defects was 83% with a specificity of
78% (Fig. 2). Compared with invasive coronary angiog-
raphy, the sensitivity to detect significant stenoses in
territories with perfusion defects was 95%, with a speci-
ficity of 65%. The combined effective dose from the stress
and rest CT myocardial perfusion scans was reported as
18 mSv.
CT: coronary CTA. The development of CT scanners and
scanning protocols continues to evolve. The diagnostic
accuracy of coronary CTA with 256 and 320 detector rows
was reported in small (n  64 to 104) single-center studies
by Chao et al. (22) and de Graaf et al. (23). In patient-based
analyses, the sensitivity to detect 50% diameter stenoses
identified on invasive coronary angiography was 99% to
100%; with a specificity of 50% to 88%.
The current evidence base for the diagnostic accuracy of
coronary CTA in single-center and multicenter trials largelyPr
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Year in Cardiac Imaging May 22, 2012:1849–60comes from academic centers with experienced observers.
Chow et al. (24) performed a field evaluation that examined
the “real world” diagnostic accuracy of coronary CTA with
various scanners and scanning protocols in 169 patients at 4
Canadian institutions. The patient-based sensitivity to de-
tect50% diameter stenoses identified on invasive coronary
ngiography ranged from 50% to 93%; the specificity ranged
rom 92% to 100%; positive predictive value ranged from
5% to 100%; and the negative predictive value ranged from
3% to 95%. On multivariate analysis, enrollment at 1
enter (which contributed 59% of the patients) was the most
mportant factor in predicting false-positive CTA results.
RI. Stress MRI first-pass perfusion imaging is an estab-
ished technique for detecting CAD that was first described
ver 20 years ago. Lockie et al. (25) attempted to improve
his technique with high spatial resolution, adenosine stress
RI with a 3-T scanner. In 52 coronary vessels, visual
ssessment of MRI perfusion had a sensitivity of 82% and
pecificity of 94% to detect vessels with abnormal fractional
ow reserve (0.75).
Coronary magnetic resonance angiography (MRA) was
lso first described over 20 years ago, but results have been
enerally disappointing. However, over the past decade,
mprovements have been made in multiple aspects of the
Figure 2 Computed Tomography MPI
Fixed myocardial perfusion defect in the anterior wall and the septum. (Left panel
myocardial blood flow (blue) in both the rest and stress images in the anterior wa
rest images is higher (red and green). (Middle panel) Radionuclide MPI shows a
anterior descending coronary artery. Reprinted, with permission, from Ho et al. (21cquisition. Kato et al. (26) used improved coronary MRA iechniques in a 7-center Japanese trial (Fig. 3). In 138
atients, coronary MRA was compared with conventional
ngiography for the detection of a 50% stenosis. The
RA examination was completed in 127 of 138 patients
92%), with a sensitivity of 88% and a specificity of 71% on
per-patient basis.
Hamdan et al. (27) performed a single-center comparison
f both 3-T coronary MRA and 64-detector-row coronary
TA with invasive coronary angiography. On a per-patient
asis, MRA showed sensitivity of 87% and specificity of
7%, which was not significantly different from CTA.
owever, Hamdan et al. compared their state-of-the art
RA technique with 64-detector coronary CTA, which is
ot the current state-of-the-art technique.
iagnosis: MI
T. Magnetic resonance imaging delayed enhancement
as used as a reference standard for 2 CT techniques for
ssessing MI. One such technique is delayed enhancement
maging with CT, which is possible because the kinetics of
T intravenous contrast material are similar to those of
RI, although enhancing tissue is less conspicuous with
T. Goetti et al. (28) evaluated CT delayed enhancement
uted tomography myocardial perfusion imaging (MPI) shows severely reduced
reas myocardial blood flow in the lateral wall and inferior wall in the stress and
efect. (Right panel) Invasive coronary angiogram showing occlusion of the left) Comp
ll, whe
fixed d
).n 24 patients with known CAD and reported 61% sensi-
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May 22, 2012:1849–60 Year in Cardiac Imagingtivity and 97% specificity for detecting a myocardial segment
with MRI delayed enhancement.
Another CT viability method involves detection of areas
of myocardial hypoperfusion during the first pass of intra-
venously injected contrast material. A relatively new CT
technique, called dual-energy imaging, improves the tissue
contrast of CT and increases the difference between per-
fused and hypoperfused myocardium. In 36 patients with
known CAD, Bauer et al. (29) used a dual-energy, first-pass
perfusion CT technique and reported 77% sensitivity and
97% specificity for identifying a myocardial segment with
MRI delayed enhancement (Fig. 4). First-pass myocardial
perfusion can be imaged with the same acquisition as
coronary CTA, creating the possibility of a “one-stop shop”
for both coronary anatomy and myocardial viability.
Figure 3 Magnetic Resonance Angiography
(A) Magnetic resonance imaging thin-slab maximum projection image of the le
shows a stenosis in the LAD (arrowhead) and a diagonal branch (arrow). (B) C
with permission, from Kato et al. (26).
Figure 4 Dual-Energy Computed Tomography Scanning
Short-axis delayed enhancement image (A) shows enhancing myocardium in the in
slice is shown, which was obtained with dual-energy computed tomography scanni
datasets—a higher-voltage (140 kV) dataset that provides superior spatial resolut
combined image the infarcted area is seen as an area of first-pass hypoperfusionPrognosis: CAD
SPECT. Bourque et al. (30) previously suggested that
SPECT could be eliminated from diagnostic studies in
patients who exercised to a workload of 10 metabolic
equivalents (METs). Two studies this year reported on
prognosis in such patients. Bourque et al. (31) followed 463
patients achieving 10 METs and reported a very low
prevalence of marked (10%) left ventricular (LV) isch-
emia, cardiac death, nonfatal MI, or late revascularization.
Lee et al. (32) followed a much larger cohort of 9,605
patients for a mean of 3.64 years. If patients attained a
workload 10 METs, marked (10%) LV ischemia oc-
curred infrequently (1% overall, and 0.7% of those without
ST-segment depression).
rior descending coronary artery (LAD) and circumflex coronary artery (LCX)
ntional catheter angiography confirms the stenoses. AO  aorta. Modified,
wall (arrows) indicating myocardial infarction. (B) A corresponding short-axis
created by overlaying 2 simultaneously acquired computed tomography
d a lower-voltage (100 kV) dataset that provides superior tissue contrast. In this
s). Modified, with permission, from Bauer et al. (29).ft ante
onveferior
ng and
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Year in Cardiac Imaging May 22, 2012:1849–60Guideline recommendations have reflected the clinical
belief that patients with severe ischemia will benefit from
revascularization. Hachamovitch et al. (33) suggested pre-
viously that patients with ischemia that exceeded 10% of the
LV benefited from revascularization but that those with
10% ischemia did not. This year, the same investigators
published an expanded study, which included patients with
previous MI and revascularization, much longer follow-up,
and all-cause mortality as an endpoint (34). Patients (n 
13,969) who underwent SPECT MPI were followed for a
median of 8.7 years. Early revascularization was associated
with better survival in patients without prior CAD or with
prior revascularization but no prior MI, but the cut-point
for benefit seemed to be closer to ischemia of 15% of the LV
(calculated from the summed difference score) rather than
Figure 5 Impact of Ischemia on Benefit of Revascularization
(A) Hazard ratio in the Cox proportional hazards model for early revascularization,
compared with medical therapy (Tx) at different values of the percent myocardium
ischemic. Shown here are the results for the 8,791 patients with no prior coronary
artery disease (no previous myocardial infarction, percutaneous coronary interven-
tion, or coronary artery bypass grafting). Medical Tx was superior at 10% ischemic
myocardium; early revascularization was superior at 15% ischemic myocardium.
(B) The same hazard ratio for the 11,880 patients with a fixed defect of 10% of
the myocardium. Again, medical Tx was superior at 10% ischemic myocardium,
and early revascularization was superior at 15% ischemic myocardium. Reprinted,
with permission, from Hachamovitch et al. (34).10% (Fig. 5).Multiple previous retrospective studies have suggested
that the assessment of myocardial viability in patients with
LV dysfunction can help identify candidates for coronary
revascularization. During the past year, the myocardial
viability substudy of the National Heart, Lung, and Blood
Institute multi-center randomized STICH (Surgical Treat-
ment for Ischemic Heart Failure) trial was published (35).
ptional viability testing with either stress SPECT or
obutamine echocardiography was performed at baseline.
f 601 patients, 487 (80%) were found to have viable
yocardium on the basis of pre-specified criteria. Patients
ithout viable myocardium were less likely to be symptom-
tic and had larger LV volumes and a higher prevalence of
revious MI. Patients with viable myocardium had lower
verall rates of death, compared with those without viable
yocardium, but this difference was no longer significant
fter adjustment for important baseline prognostic variables
e.g., ejection fraction [EF]). The presence of myocardial
iability did not predict better outcome with coronary artery
ypass grafting (Fig. 6).
Figure 6 Impact of Viability on Benefit of Revascularization
(A) Kaplan-Meier intention-to-treat analysis of the probability of death in
patients with myocardial viability, according to the initial randomization assign-
ment to coronary artery bypass grafting (CABG) or medical therapy (Tx). Survival
at 5 years was 31.2% in the CABG group and 35.4% in the medical Tx group.
(B) Formal statistical analysis of interaction between treatment assignment to
CABG or medical Tx and the presence or absence of viability. The interaction
was not significant (p  0.53). CI  confidence interval. Reprinted, with per-
mission, from Bonow et al. (35).
Prognostic Studies of CTA in >1,000 PatientsTable 2 Prognostic Studies of CTA in >1,000 Patients
First Author
(Ref. #) N CAD, % Follow-Up
Lost to
Follow-Up, % Excluded, % Events n %
Clinical Factors
Adjustment Findings Reclass?
Kwon (36) 4,338 0 828 380 days 0.1% 8.3% CD 2 0.05 Age AUC (CAC) AUC (RF) No
NMI 3 0.08 Sex AUC (CTA) AUC (CAC)
UA 1 0.03 HBP AUC (CTA/CAC)  AUC (CTA)
Revasc 99 2.50 DM
Lipid
Hadamitzky (37) 2,387 0 29 (17–42) months 4.1% 2.8% CD 4 0.2 Morise AUC (CAC) AUC (Morise) Yes, by group only
NMI 8 0.4 AUC (CTA) AUC (CAC)
UA 4 0.2
Revasc 31 1.4
Van Werkhoven (38) 1,467 11 2.2 (1.3–3.2) yrs 8% 10% D 40 3.3 Age Obst CAD more prognostic in
smokers (p  0.03)
No
NMI 12 1.1 DM
Lipid
Obesity
Known CAD
Chow (39) 14,064 0 22.5 months 0.7% 0% D 271 1.9 Age AUC (ATP/EF) AUC (ATP) Yes, individual
patients but only
with normal/
abnormal EF
CP
BMI
RF
ATP
AUC (CTA/ATP/EF) AUC (ATP/EF)
ATP  risk by National Cholesterol Education Project/Adult Treatment Panel Score; AUC  appropriate use criteria; BMI  body mass index; CAD  coronary artery disease; CD  cardiac death; CP  chest pain; CTA  computed tomography angiography; D  death;
DM  diabetes; HBP  hypertension; Morise  pre-test risk according to Morise; NMI  nonfatal myocardial infarction; Obst  obstructive CAD by CT; % CAD  prevalence of CAD in study group; Revasc  revascularization (late); Reclass  reclassification analysis; RF 
risk factors; UA  unstable angina.
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Year in Cardiac Imaging May 22, 2012:1849–60These results were limited by incomplete myocardial
viability data, the small number of patients without myo-
cardial viability, the potential impact of viability testing on
clinical decision making, and the absence of data on other
imaging approaches, such as PET or MRI. The definition
of viability for SPECT did not consider regional wall
motion. The vast majority of the enrolled patients (80%)
were enrolled outside the United States.
CTA. Several large studies of the prognostic value of
CTA were published during the past year (Table 2)
(36 – 40). The largest of these was the multicenter study
of 14,064 patients reported by Chow et al. (39), which
Figure 7 Magnetic Resonance Assessment of Acute MI
Short-axis magnetic resonance image in a patient with acute ST-segment elevation
of enhancing (i.e., infarcted) tissue in the anterior wall and septum (arrow). Centr
microvascular obstruction. (B) Corresponding T2-weighted (edema-sensitive) im
within the edema, there is a low signal area (arrow), which on this sequence i
from Eitel et al. (44).
Figure 8 Computed Tomography Assessment of Coronary Plaqu
Coronary artery plaque morphology by coronary computed tomography angiogra
components, which closely resembles the ulceration with dye penetration into
Madder et al. (46).found that CTA added to clinical variables and EF
(considered as normal/abnormal) in ROC analysis of
subsequent events.
MRI. With MRI, multiple parameters can be imaged at 1
setting, making it a powerful tool for assessing prognosis in
CAD. Korosoglou et al. (41) studied 1,493 patients with
dobutamine stress MRI, assessed both wall motion and
perfusion, and followed patients for 2 years for cardiac death
or nonfatal MI. Inducible wall motion abnormalities and
inducible perfusion defects were both associated with ad-
verse outcomes on univariate and multivariate analysis (p 
.001 for both).
ardial infarction. (A) Short-axis delayed enhancement image shows a large area
thin the infracted tissue, there is an area of decreased signal, indicating
hows a large amount of edema in the region of the infarct (arrow). Centrally
ght to represent hemorrhage within the infarction. Modified, with permission,
ft) shows ulceration (arrow) within a plaque with calcified and noncalcified
ronary wall on invasive angiography (right). Reprinted, with permission, frommyoc
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May 22, 2012:1849–60 Year in Cardiac ImagingFarzaneh-Far et al. (42) performed dobutamine stress MRI
and evaluated inducible wall motion abnormalities, presence of
delayed enhancement, and stress-induced change in left atrial
EF in 122 patients. They followed the patients for 23 months
(range 6 to 54 months) for a combined endpoint of all-cause
mortality, acute MI, unstable angina, or heart failure. The
change in left atrial EF predicted events in a multivariate
model adjusted for clinical variables and MRI imaging vari-
ables. The measurement of left atrial ejection might be a
surrogate for changes in myocardial relaxation.
Bingham and Hachamovitch (43) performed adenosine
stress MRI in 908 patients who they followed for 2.6 years for
all-cause mortality, MI, or late revascularization. The MRI
examination included adenosine perfusion, delayed enhance-
ment, stress-induced wall motion abnormalities, LV volumes,
and aortic blood flow evaluation. On multivariable analysis, the
authors found that models that included all of the MRI data
had increased prognostic power. However, delayed enhance-
ment and stress-induced perfusion did not provide indepen-
dent prognostic information to each other. The net reclassifi-
cation rate was 3.5% for stress perfusion data. Risk
reclassification was not reported for stress wall motion.
Several studies in recent years have reported novel MRI
parameters for predicting outcomes after acute MI, includ-
ing the hypointense core within the infarct seen on T2-
weighted images.
Eitel et al. (44) studied 346 patients with ST-segment
elevation MI, who were reperfused with percutaneous cor-
onary intervention and followed for 6 months for a com-
posite outcome of death, new MI, or new congestive heart
failure (Fig. 7). The ROC analysis showed that the hypoin-
tense core added prognostic information to clinical (pre-
imaging) variables, LVEF, and infarct size. Patient reclas-
sification was not assessed.
Vascular Structure and Function
CT. The direct visualization of coronary artery plaque with
oronary CTA might permit identification of morphologic
eatures that predict further plaque rupture and identify
revious rupture.
Gauss et al. (45) studied 48 coronary plaques in 38
elected patients with good or excellent image quality
ho had undergone intravascular ultrasound and dual-
ource coronary CTA within 24 h. Remodeling index was
alculated from the ratio of the maximally narrowed area
o the reference segment area. The correlation between
oronary CTA and intravascular ultrasound was higher
or vessel area measurements (r  0.9, p  0.0001) than
or remodeling indexes (r  0.7, p  0.0001). Bland-
ltman analysis showed a systematic overestimation of
essel areas and remodeling indexes by coronary CTA.
hese data demonstrate the difficulty of accurately iden-
ifying the external elastic lamina on coronary CTA and
he current limitations of coronary CTA for the assess-
ent of remodeling. Ne T
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Year in Cardiac Imaging May 22, 2012:1849–60Madder at al. (46) performed a “proof-of-concept”
study to establish whether coronary CTA can identify
morphological features of plaque disruption. They exam-
ined 294 plaques causing 25% stenoses in 60 patients
with unstable angina who underwent invasive coronary
angiography. Compared with plaques without disruption,
the 109 plaques (37%) that showed features of disruption
on CTA had a higher volume, were more often positively
remodeled, contained more low-attenuation plaque, and
were more often “complex” by invasive coronary angiog-
raphy. Coronary CTA features of disruption had sensi-
tivity of 53% to 81% and specificity of 82% to 95% for
identifying plaque that was “complex” by invasive coro-
nary angiography (ulcerations, filling defects, haziness,
irregular margins, fissuring) (Fig. 8).
Ventricular Function
CT. The higher temporal resolution of cardiac CT imaging
with current scanners permits better imaging of global and
regional myocardial function.
Studies Published This Year on Imaging Use and AppropriatenessTable 4 Studies Published This Year on Imaging Use and Appro
First Author
(Ref. #) Database N
Years of
Study
Levin (56) Medicare Part B
master files
35 million fee-for-service
beneficiaries
1998–2008
Levin (57) Medicare Part B
master files
35 million fee-for-service
beneficiaries
1998–2008
Levin (58) Medicare Part B
master files
35 million fee-for-service
beneficiaries
1998–2008
Shah (61) Insurance database 28,177 2004–2007
Carryer (59) Single center 281 2005
Carryer (60) Single center 2,354 2002
Gibbons (62) Single center 841 2005–2008
Koh (63) Single center 1,623 2009CABG coronary artery bypass graft surgery; CME continuing medical education; echo echocardiogra
intervention; other abbreviations as in Table 3.Seneviratne et al. (47) examined the incremental diag-
nostic value of regional LV function compared with coro-
nary CTA for the detection of acute coronary syndromes in
356 patients. Cardiac CT datasets were acquired with
retrospective gating on a 64-slice scanner. Thirty-one pa-
tients were diagnosed with acute coronary syndrome (8 MI,
22 unstable angina), of whom 23 (74%) had regional wall
motion abnormalities. The sensitivity of cardiac CT to
detect acute coronary syndromes was 77%, on the basis of
coronary CTA alone, and increased to 87% (95% confidence
interval: 70% to 96%) if regional wall motion abnormalities
were added as a diagnostic criterion.
Boogers et al. (48) compared diastolic function assess-
ment by 64-slice cardiac CT with echocardiography in 70
patients with known or suspected CAD. The CT projection
data were reconstructed at 20 intervals across the cardiac
cycle. From these data, 1 blinded observer derived peak
transmitral velocities, ratios between early and late ventric-
ular filling velocity (E/A ratios), and mitral septal tissue
velocities. Compared with echocardiographic pulsed-wave
eness
Imaging
Modality Endpoint Major Findings
I, nuclear
medicine,
CT, echo,
ultrasound
Number of imaging
tests/1,000
beneficiaries
Compound growth rate 4.1%
1998–2005, decreased to 1.4%
2005–2008. Similar decreases for
radiologists and nonradiologists
ninvasive
diagnostic
tests
Payments by physician
specialty
From 1998–2006, rate of growth in
nonradiologists radiologists.
2006–2008, decreases for
radiologists nonradiologists
/SPECT
MPI
Number of tests/
100,000 beneficiaries
MPI 4,748 in 1998, 8,753 in 2006,
and 8,467 in 2008. CTA 99 in
2006, 210 in 2007, and 193 in
2008.
ess ECG
ess MPI
ess echo
Rates of testing after
PCI/CABG
59% had a stress test within
24 months, with increases at
6 and 12 months
ECT MPI Appropriateness Compared with 2005 AUC, 2009
AUC, eliminated unclassified
patients, and increased
inappropriate studies from
14.6% to 24.2%
ECT MPI Follow-up imaging after
normal stress scan
In patients without prior CAD, routine
scans performed in 13% and well
before the end of the “warranty
period.” In patients with known
CAD, routine scans performed in
26%, and generally after the end
of the “warranty period.” Routine
scans had minimal impact on
referral to catheterization or
revascularization.
ess SPECT
MPI
Appropriateness QI project focused on CME did not
improve appropriateness
ECT MPI Appropriateness 10% inappropriate, 5% uncertain,
3% unclassified. Inappropriate
studies more frequent in
asymptomatic patients and
preoperative patients.priat
MR
No
CTA
Str
Str
Str
SP
SP
Str
SPm; MRImyocardial perfusion imaging; QI quality improvement; PCI percutaneous coronary
1859JACC Vol. 59, No. 21, 2012 Gibbons et al.
May 22, 2012:1849–60 Year in Cardiac ImagingDoppler and color-coded tissue Doppler imaging, good
correlations were observed for the assessment of early
transmitral velocity (E) (R  0.73; p  0.01), E/A ratio
(R  0.87; p  0.01), and early diastolic peak mitral septal
tissue velocities (R  0.82; p  0.01).
Appropriateness of Imaging
Within the past year, there have been multiple new and
revised clinical practice guidelines, position statements, and
appropriateness criteria published relating to the modalities
covered in this review (Table 3) (49–55). The single most
important of these was the new American College of
Cardiology Foundation/American Heart Association clini-
cal practice guideline with regard to asymptomatic individ-
uals without CAD (49). This guideline included Class IIa
recommendations for CAC in patients with intermediate-
risk Framingham scores as well as patients with diabetes
mellitus. Other pertinent recommendations are summarized
in Table 3.
Reflecting the societal interest in imaging use and
appropriateness, multiple studies were published this year
on this issue. The most important of these are summa-
rized in Table 4 (56 – 63).
Conclusions
We continue to hope that these articles will inspire readers
to examine individual publications in more detail in an effort
to better use imaging in their everyday clinical practice.
Reprint requests and correspondence: Dr. Raymond J. Gibbons,
Mayo Clinic, Gonda 5, 200 First Street Southwest, Rochester,
Minnesota 55905. E-mail: gibbons.raymond@mayo.edu.
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